Back to results
US 2021/0277417 A1Published application
Methods of treating clrn1-associated hearing loss and/or vision loss
AssigneeAkouos, Inc.
InventorsEmmanuel John Simons, Robert Ng
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions that include a single nucleic acid vector or two different nucleic acid vectors, and the use of these compositions to treat hearing loss and/or vision loss in a subject.
Claims26
-228. (canceled)
A method comprising:
- introducing into a cochlea of a mammal a therapeutically effective amount of a composition comprising a single nucleic acid vector, wherein the vector comprises a first coding sequence encoding a first isoform of CLRN1 protein,
- wherein the first coding sequence comprises a nucleotide sequence spanning two consecutive exons of a CLRN1 genomic DNA, and lacking an intronic sequence between the two consecutive introns.
A composition comprising a single nucleic acid vector, wherein the vector comprises:
- a first coding sequence encoding a first isoform of CLRN1 protein,
- wherein the first coding sequence comprises a nucleotide sequence spanning two consecutive exons of a CLRN1 genomic DNA, and lacking an intronic sequence between the two consecutive introns.
Dependencies are inferred from the claim text.